Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Asset disposition
|
|
EDEN BIOSCIENCE CORP (EDEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/02/2006 |
8-K
| Quarterly results |
| 08/03/2006 |
8-K
| Quarterly results |
| 05/04/2006 |
8-K
| Quarterly results |
| 02/23/2006 |
8-K
| Quarterly results |
| 10/27/2005 |
8-K
| Quarterly results |
| 07/26/2005 |
8-K
| Quarterly results |
| 04/28/2005 |
8-K
| Quarterly results |
| 02/17/2005 |
8-K
| Quarterly results |
| 10/26/2004 |
8-K
| Quarterly results |
| 07/22/2004 |
8-K
| Quarterly results|
Docs:
|
"Eden Bioscience Announces Second Quarter 2004 Financial Results BOTHELL, WA, July 22, 2004 — Eden Bioscience Corporation , which develops, manufactures and markets innovative, natural protein-based products for improving crop production and protecting plants, today announced financial results for its second quarter ended June 30, 2004. Product sales, net of sales allowances, for the second quarter of 2004 were $290,000, which compares to net product sales of $549,000 in the same period of 2003. Net loss in the second quarter of 2004 was $2.0 million, or $0.08 per weighted average common share, compared to a net loss of $3.3 million, or $0.14 per weighted average common share, in the second quarter of 2003. Per-share loss amounts for the quarters are based on weighted average common shares ..." |
|
| 04/22/2004 |
8-K
| Quarterly results |
| 02/12/2004 |
8-K
| Quarterly results|
Docs:
|
"Eden Bioscience Announces Fourth Quarter and Year End 2003 Financial Results BOTHELL, WA — — February 12, 2004 — Eden Bioscience Corporation , which develops, manufactures and markets innovative, natural protein-based products for improving crop production and protecting plants, today announced financial results for its fourth quarter and fiscal year ended December 31, 2003. Net product sales for the fourth quarter of 2003 were $274,000, which compares to net product sales of $219,000 in the fourth quarter of 2002. Net product sales for the year ended December 31, 2003 were $1.8 million. This includes the elimination of $126,000 of sales allowance liabilities recognized in prior quarters that will not be paid because of changes in distribution programs implemented in 2003 and actual amount..." |
|
| 10/23/2003 |
8-K
| Quarterly results |
|
|